This site is intended for Healthcare Professionals only.

UWE Bristol and Bedminster Pharmacy to pioneer antimicrobial stewardship

Date:

Share post:

The collaboration between UWE Bristol and Bedminster Pharmacy to address societal challenges

In a collaborative effort to combat the escalating threat of antimicrobial resistance (AMR), UWE Bristol and Bedminster Pharmacy have secured grant funding from the UKRI Regional Innovation Fund (RIF) for a groundbreaking 4-month project.

This initiative aims to revolutionise antimicrobial stewardship (AMS) practices at the community pharmacy level, addressing the pressing need for evidence-based approaches in tackling AMR.

With antibiotic misuse contributing significantly to the rise of AMR, the project underscores the vital role of community pharmacies in promoting responsible antibiotic use.

Mr Ade Williams, Superintendent Pharmacist at Bedminster Pharmacy, emphasised the significance of this endeavour, stating:

‘‘The emerging role of Community Pharmacy offering timely accessible clinical interventions, including prescribing antibiotics, will undoubtedly help address the increasing demands on the NHS.”

“It is also an exciting opportunity to embed evidence-based AMS principles and practice. Aligning these opportunities effectively is an important challenge to address, and I am grateful for this project,” he continued.

Led by Dr Emmanuel Adukwu from the Centre for Research in Biosciences (CRIB) at UWE Bristol, the project promises to deliver innovative solutions to enhance AMS practices.

Dr Adukwu brings extensive expertise in antimicrobial resistance and infection prevention, ensuring a robust scientific foundation for the project.

Joining the endeavour is Obiageli Okolie, a post-doctoral researcher at UWE Bristol, renowned for her contributions to public health research.

Okolie’s expertise in antimicrobial resistance and stewardship toolkit development further enriches the project’s potential impact.

Reflecting on the collaboration, Mr Ade Williams expressed enthusiasm, affirming his excitement  about “working with the UWE to improve our pharmacy practice and combat antimicrobial resistance together.”

Dr Vincent Cheng, a community pharmacist and Lecturer at the University of Bristol, commended the partnership, stating:

““I am very impressed by the wealth of knowledge and experience brought by the UWE team.

I am confident that they will provide an evidence-based solution to improve pharmacists’ knowledge and practice in the area [antimicrobial resistance],” he added.

The Regional Innovation Fund (RIF) serves as a cornerstone in supporting transformative projects like this.

It fosters collaboration between universities and local industries to address pressing societal challenges.

Through initiatives like this, stakeholders are poised to make meaningful strides in safeguarding public health and promoting sustainable antimicrobial stewardship.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...